Latest Breaking News On - Ziopharm oncology inc - Page 1 : comparemela.com

TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer

29.01.2024 - WALTHAM, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) - TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of . Seite 1

Global Natural Killer Cells Therapeutics Research Report

Dublin, Jan. 03, 2024 (GLOBE NEWSWIRE) The

Natural Killer Cells Therapeutics Market Analysis and Industry Forecast Report 2023: Focus on Cancer Immunotherapy, Infectious Diseases and Autoimmune Disorders

/PRNewswire/ The "Natural Killer Cells Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2027" report has been added to.

Spero Therapeutics Appoints Sath Shukla as President & Chief Executive Officer

Biorefinery Products Global Markets Report 2022: Market Revenue for 2021, Estimates for 2022, and CAGR Projections Through 2027

/PRNewswire/ The "Biorefinery Products: Global Markets" report has been added to ResearchAndMarkets.com s offering. This research report quantifies the two.